Saturday, July 11, 2026

Drug profile · INN

ceftolozane

ceftolozane (ZERBAXA) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Antiinfectives for systemic use (J01) J01DI54
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ceftolozane
Class
Antiinfectives for systemic use (J01)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

ceftolozane (ZERBAXA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN ceftolozane
Brand ZERBAXA
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01DI54

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. APHP180596 Phase 3 · PARItec · antibiotic therapy in Sepsis
  2. Ceftolozane/tazobactam Approved · Sunshine Guojian Pharmaceutical · Bronchiectasis

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is ceftolozane?

ceftolozane (ZERBAXA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for ceftolozane?

ZERBAXA is a marketed brand name for ceftolozane. Check FDA Drugs@FDA for the current US label holder and prescribing information.